The transcription factor NRF2, which promotes cell survival following oxidative damage, is one of the best described targets of CUL3 in the context of cancer through the interaction of CUL3 with the BTB/POZ domain protein Keap1 (39–41). The gene discussed is CUL3; the disease is cancer.